GF
IMUC

Gerstein Fisher’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Gerstein Fisher’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-325
Closed -$5K – 444
2015
Q4 		$5K Hold
325
– – ﹤0.01% 406
2015
Q3 		$5K Hold
325
– – ﹤0.01% 403
2015
Q2 		$6K Hold
325
– – ﹤0.01% 402
2015
Q1 		$6K Hold
325
– – ﹤0.01% 407
2014
Q4 		$9K Hold
325
– – ﹤0.01% 385
2014
Q3 		$12K Hold
325
– – ﹤0.01% 382
2014
Q2 		$15K Hold
325
– – ﹤0.01% 336
2014
Q1 		$16K Sell
325
-325
-50% -$15.9K ﹤0.01% 330
2013
Q4 		$24K Buy
650
+400
+160% +$37.9K ﹤0.01% 445
2013
Q3 		$26K Sell
250
-250
-50% -$27.4K 0.01% 360
2013
Q2 		$39K Buy
+500
New +$47.9K 0.01% 327

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.6B AUM 27.3% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $2.24B AUM 17.11% 1-Year Est. Return